{
  "data_version": "seed-0.7 · marketcap-1 · 2026-08-30",
  "source": "https://finance.foundation",
  "license": {
    "finance_foundation_data": "CC BY 4.0 — attribution: Finance Foundation (https://finance.foundation)",
    "upstream_values": "Fields sourced from a provider carry their own source field and remain under that provider's terms — see https://finance.foundation/api/v1/sources"
  },
  "entity": "company",
  "data": {
    "id": "astrazeneca",
    "name": "AstraZeneca",
    "legal_name": "AstraZeneca PLC",
    "ticker": "AZN",
    "exchange": "lse",
    "country": "united-kingdom",
    "sector": "Healthcare",
    "industry": "Pharmaceuticals",
    "market_cap_usd_bn": 252.2,
    "currency": "GBP",
    "website": "https://www.astrazeneca.com",
    "founded": 1999,
    "description": "Anglo-Swedish pharmaceutical company formed by the 1999 merger of Astra AB and Zeneca Group, with major franchises in oncology, cardiovascular and rare diseases. One of the largest companies on the London Stock Exchange.",
    "identifiers": {
      "lei": "PY6ZZQWO2IZFZC3IOL08",
      "isin": "GB0009895292",
      "figi": "BBG001SCNW31"
    },
    "market_cap_seed_usd_bn": 230,
    "market_cap_basis": "computed",
    "market_cap_as_of": "2026-08-28",
    "market_cap": {
      "usd_bn": 252.2,
      "method": "shares_outstanding x price",
      "shares_outstanding": 1550957927,
      "shares_basis": "outstanding",
      "shares_as_of": "2025-12-31",
      "shares_source": "SEC 20-F cover page (2025-12-31)",
      "shares_source_url": "https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/R1.htm",
      "price": 11970,
      "price_currency": "GBp",
      "price_date": "2026-08-28",
      "price_symbol": "AZN.L",
      "price_venue": "LSE",
      "fx": "ECB euro reference rates, 2026-08-28",
      "adr_ratio": 1,
      "caveat": "ADR programme terminated - this is the big trap. Shareholders approved listing harmonisation on 3 Nov 2025 and it took effect 2 February 2026: AstraZeneca's ordinary shares of US$0.25 are now listed directly on the London Stock Exchange, Nasdaq Stockholm and the New York Stock Exchange, all under the symbol AZN (AstraZeneca Annual Report & Form 20-F 2025, 'Shareholder information')."
    },
    "fundamentals": {
      "period": "2025-12-31",
      "form": "20-F",
      "filed": "2026-02-24",
      "filing_url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000901832&type=20-F&dateb=&owner=include&count=10",
      "reporting_currency": "USD",
      "fx": null,
      "note": "Every metric comes from the same annual filing; a metric absent from that filing is absent here rather than taken from another year. Each carries the XBRL tag it was read from.",
      "metrics": {
        "net_income": {
          "value": 10233000000,
          "usd": 10233000000,
          "tag": "ifrs-full:ProfitLoss",
          "start": "2025-01-01",
          "end": "2025-12-31"
        },
        "assets": {
          "value": 114074000000,
          "usd": 114074000000,
          "tag": "ifrs-full:Assets",
          "start": null,
          "end": "2025-12-31"
        },
        "rnd": {
          "value": 14232000000,
          "usd": 14232000000,
          "tag": "ifrs-full:ResearchAndDevelopmentExpense",
          "start": "2025-01-01",
          "end": "2025-12-31"
        }
      }
    }
  },
  "field_provenance": {
    "market_cap_usd_bn": "Computed, not copied: shares outstanding from the issuer's own filing x the closing price on its home listing. The inputs, their dates and the filing URL are in the `market_cap` object; null means we hold no share count we can source. `market_cap_seed_usd_bn` is the superseded hand-entered value, kept only so the two can be told apart.",
    "founded": "Company's own corporate history / registration record.",
    "sector": "Finance Foundation classification, not GICS or ICB (both licensed).",
    "identifiers": {
      "lei": "GLEIF (CC0) — free to redistribute",
      "isin": "Issuer's own primary listing document; ISO 6166 check digit validated. For a company carried via its US ADR this is the ADR ISIN — see us_listing_type",
      "figi": "OpenFIGI (open standard) — free to redistribute"
    }
  },
  "links": {
    "html": "https://finance.foundation/companies/astrazeneca",
    "graph": "https://finance.foundation/api/v1/graph/companies/astrazeneca",
    "sources": "https://finance.foundation/api/v1/sources"
  }
}